| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 23 2D1 | GROUP:2D1_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 41 2D1 | GROUP:2D1_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 5 2D1 | GROUP:2D1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 9 2D2 | GROUP:2D2_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 27 2D2 | GROUP:2D_2_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 45 2D2 | GROUP:2D2_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 14 2D3 | GROUP:2D3_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 32 2D3 | GROUP:2D3_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 50 2D3 | GROUP:2D3_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 18 2D4 | GROUP:2D4_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 36 2D4 | GROUP:2D4_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 54 2D4 | GROUP:2D4_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 8 P1C | GROUP:Core1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 26 P1C | GROUP:Core_1_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 44 P1C | GROUP:Core1_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 12 P2C | GROUP:Core2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 30 P2C | GROUP:Core2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 48 P2C | GROUP:Core2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 17 P3C | GROUP:Core3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 35 P3C | GROUP:Core3_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 53 P3C | GROUP:Core3_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 21 P4C | GROUP:Core4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 39 P4C | GROUP:Core4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 57 P4C | GROUP:Core4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 7 P1M | GROUP:Middle1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 25 P1M | GROUP:Middle1_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 43 P1M | GROUP:Middle1_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 11 P2M | GROUP:Middle2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 29 P2M | GROUP:Middle2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 47 P2M | GROUP:Middle2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 16 P3M | GROUP:Middle3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 34 P3M | GROUP:Middle3_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 52 P3M | GROUP:Middle3_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 20 P4M | GROUP:Middle4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 38 P4M | GROUP:Middle4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 56 P4M | GROUP:Middle4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 6 P1O | GROUP:Outer1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 42 P1O | GROUP:Outer1_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 10 P2O | GROUP:Outer2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 28 P2O | GROUP:Outer2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 46 P2O | GROUP:Outer2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 24 P1O | GROUP:Outer_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 15 P3O | GROUP:Outer3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 33 P3O | GROUP:Outer3_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 51 P3O | GROUP:Outer3_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 19 P4O | GROUP:Outer4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 37 P4O | GROUP:Outer4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 55 P4O | GROUP:Outer4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 59 QC20 | GROUP:QC10 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 60 QC40 | GROUP:QC11 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 2 QC10 | GROUP:QC1 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 3 QC20 | GROUP:QC2 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 4 QC40 | GROUP:QC3 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 13 QC10 | GROUP:QC4 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 22 QC20 | GROUP:QC5 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 31 QC40 | GROUP:QC6 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 40 QC20 | GROUP:QC7 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 49 QC40 | GROUP:QC8 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase POSITIVE ION MODE | 58 QC10 | GROUP:QC9 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 23 2D1 | GROUP:2D1_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 41 2D1 | GROUP:2D1_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 5 2D1 | GROUP:2D1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 9 2D2 | GROUP:2D2_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 27 2D2 | GROUP:2D_2_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 45 2D2 | GROUP:2D2_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 14 2D3 | GROUP:2D3_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 32 2D3 | GROUP:2D3_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 18 2D4 | GROUP:2D4_1 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 36 2D4 | GROUP:2D4_2 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 54 2D4 | GROUP:2D4_3 | TYPE:2D | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 8 P1C | GROUP:Core1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 26 P1C | GROUP:Core_1_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 12 P2C | GROUP:Core2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 30 P2C | GROUP:Core2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 48 P2C | GROUP:Core2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 17 P3C | GROUP:Core3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 35 P3C | GROUP:Core3_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 21 P4C | GROUP:Core4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 39 P4C | GROUP:Core4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 57 P4C | GROUP:Core4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 7 P1M | GROUP:Middle1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 25 P1M | GROUP:Middle1_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 43 P1M | GROUP:Middle1_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 11 P2M | GROUP:Middle2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 29 P2M | GROUP:Middle2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 47 P2M | GROUP:Middle2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 16 P3M | GROUP:Middle3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 20 P4M | GROUP:Middle4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 38 P4M | GROUP:Middle4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 56 P4M | GROUP:Middle4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 6 P1O | GROUP:Outer1_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 42 P1O | GROUP:Outer1_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 10 P2O | GROUP:Outer2_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 28 P2O | GROUP:Outer2_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 46 P2O | GROUP:Outer2_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 24 P1O | GROUP:Outer_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 15 P3O | GROUP:Outer3_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 33 P3O | GROUP:Outer3_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 19 P4O | GROUP:Outer4_1 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 37 P4O | GROUP:Outer4_2 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 55 P4O | GROUP:Outer4_3 | TYPE:SPHEROID | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 2 QC10 | GROUP:QC1 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 3 QC20 | GROUP:QC2 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 13 QC10 | GROUP:QC4 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 22 QC20 | GROUP:QC5 | TYPE:QC | pmol lipid/ ug protein |
| Reversed phase NEGATIVE ION MODE | 31 QC40 | GROUP:QC6 | TYPE:QC | pmol lipid/ ug protein |
Return to study ST002070 main page
Download data matrix(Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Reversed phase POSITIVE ION MODE)
Download data matrix(Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|